Search results for

Universities are raising food and housing prices faster than inflation.

In the final story of our "Bad Days in History" series this week, author Michael Farquhar shares a story from England in 1632.

Doctors hand out cholesterol-lowering statins like breath mints, but like any drug they come with risks. Less heart disease, sure, a slightly higher risk of diabetes, too. So what's a person to do?

For 50 years, this little-known archive of civil rights activities has gone pretty much untouched and untapped.

The Flynn saga involves two presidents, a foreign ambassador, one fired FBI director and a lot of talk about Russian sanctions.

Guest bloggers Henry Wellman and Kimberly Brink reflect on their new study shedding light on how adults, older children and young children perceive human-like robots — and what the future might hold.

In 2002, Donald Trump was expected to be a savior for Rancho Palos Verdes. But over the next decade, he brought lawsuits and offended residents. It's a lesson in Trump's management style.

The Republican tax plan could reduce or eliminate federal tax credits that reward companies for developing drugs to treat rare diseases. People who benefit from the medicines have objected.

In an interview with NPR, the House speaker said the tax bill was "designed" as a middle-class tax cut. But in reality, at its core, it is a corporate tax cut.

NPR's Steve Inskeep talks with former Army Gen. Martin Dempsey about his new book Radical Inclusion, in which he argues that the demands of leadership have changed since Sept. 11.